2025-03-29 18:16:50
Latest Post
Cineline India Ltd monetizes Hotel Asset for INR 270 crores, becomes Net Debt-Free company
Emami Realty Limited appoints Ms. Ishani Ray as additional director
The Ramco Cements Ltd increases cement grinding capacity by 0.4 MTPA
Manappuram Finance Limited board approves fund raising program for FY 2025-26
Adani Renewable Energy Fifty Seven Ltd commissions incremental solar power project of 37.50 MW at Khavda
Stock Report
ZIM Laboratories Ltd consolidated Q3 FY2023-24 net profit up QoQ at Rs. 4.78 crores
Posted On : 2024-01-29 17:45:02( TIMEZONE : IST )
Zim Laboratories Ltd has reported Consolidated financial results for the period ended December 31, 2023.
Financial Results (Q3 FY2024) - QoQ Comparison
The company has reported total income of Rs. 97.4049 crores during the period ended December 31, 2023 as compared to Rs. 87.2476 crores during the period ended September 30, 2023.
The company has posted net profit / (loss) of Rs. 4.7846 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs. 4.1495 crores for the period ended September 30, 2023.
The company has reported EPS of Rs. 0.98 for the period ended December 31, 2023 as compared to Rs. 0.85 for the period ended September 30, 2023.
| Financials | Q3 FY2024 | Q2 FY2024 | % Change |
| Total Income | ₹ 97.4049 crs | ₹87.2476 crs |  11.64% |
| Net Profit | ₹4.7846 crs | ₹4.1495 crs | 15.31% |
| EPS | ₹0.98 | ₹0.85 | 15.29% |
Financial Results (Q3 FY2024) - YoY Comparison
The company has reported total income of Rs. 97.4049 crores during the period ended December 31, 2023 as compared to Rs.103.3747 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs.4.7846 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs.6.6006 crores for the period ended December 31, 2022.
The company has reported EPS of Rs.0.98 for the period ended December 31, 2023 as compared to Rs.1.35 for the period ended December 31, 2022.
| Financials | Q3 FY2024 | Q3 FY2023 | % Change |
| Total Income | ₹ 97.4049 crs | ₹103.3747 crs |  -5.77% |
| Net Profit | ₹4.7846 crs | ₹6.6006 crs | -27.51% |
| EPS | ₹0.98 | ₹1.35 | -27.41% |
Financial Results (9 Months Ended FY2024) - YoY Comparison
The company has reported total income of Rs.253.2108 crores during the 9 Months period ended December 31, 2023 as compared to Rs.298.8353 crores during the 9 Months period ended December 31, 2022.
The company has posted net profit / (loss) of Rs.9.1607 crores for the 9 Months period ended December 31, 2023 as against net profit / (loss) of Rs.17.1981 crores for the 9 Months period ended December 31, 2022.
The company has reported EPS of Rs.1.88 for the 9 Months period ended December 31, 2023 as compared to Rs.3.53 for the 9 Months period ended December 31, 2022.
| Financials | 9 Months Ended FY2024 | 9 Months Ended FY2023 | % Change |
| Total Income | ₹253.2108 crs | ₹298.8353 crs | -15.27% |
| Net Profit | ₹9.1607 crs | ₹17.1981 crs | -46.73% |
| EPS | ₹1.88 | ₹3.53 | -46.74% |
Shares of Zim Laboratories Ltd was last trading in BSE at Rs. 108.75 as compared to the previous close of Rs. 108.95. The total number of shares traded during the day was 4937 in over 216 trades.
The stock hit an intraday high of Rs. 113.00 and intraday low of 108.50. The net turnover during the day was Rs. 546981.00.
